Scientist, Cell Pharmacology
Greater Boston
• Developed and validated 10+ custom cell-based assays and ELISAs to characterize and screen novel immuno-oncology therapeutics, leading to go/no-go decisions • Optimized enzymatic cleavage reactions to enhance efficiency, mitigate downstream effects, and streamline high-throughput assays• Developed and implemented assays for clinical stage molecules; worked with key stakeholders to ensure the development team was aligned with techniques, progress, and results. Documented findings in a report for regulatory filing• Generated data on molecules across the platform aligned with the programs’ target candidate profile (TCP) to enable the selection of development candidates (DCs) and IND filings • Cultured and maintained multiple cell lines (adherent and suspension) simultaneously• Cryopreserved and banked cells for the department following established LIMS practices • Performed routine assays to QC 1000+ molecules for release for downstream characterization assays and to funnel candidates for DC nomination• Maintained detailed experimental information and data analyses in ELN entries • Generated and presented figures and slide decks to communicate results and proposals for interdepartmental project team meetings, allowing for quick, clear decisions • Wrote and transferred SOPs to internal departments and CROs, allowing for seamless and timely transition of assays and key data generation• Served as the Cell Pharmacology representative for three cross-functional discovery projects. Collaborated interdepartmentally on complex experiments and data packages to inform platform questions and project teams• Reviewed literature and remained informed on the latest advances in the competitive landscape and was an active member of the Xilio Journal Club• Collaborated with the CMC, Non-clinical Development, Toxicology, and Clinical teams• Served as a member of the laboratory safety committee to ensure compliance with local regulations